Cargando…
Placenta-derived mesenchymal stem cells improve memory dysfunction in an Aβ(1–42)-infused mouse model of Alzheimer's disease
Mesenchymal stem cells (MSCs) promote functional recoveries in pathological experimental models of central nervous system (CNS) and are currently being tested in clinical trials for neurological disorders, but preventive mechanisms of placenta-derived MSCs (PD-MSCs) for Alzheimer's disease are...
Autores principales: | Yun, H-M, Kim, H S, Park, K-R, Shin, J M, Kang, A R, il Lee, K, Song, S, Kim, Y-B, Han, S B, Chung, H-M, Hong, J T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877561/ https://www.ncbi.nlm.nih.gov/pubmed/24336078 http://dx.doi.org/10.1038/cddis.2013.490 |
Ejemplares similares
-
Loss of Cdc42 leads to defects in synaptic plasticity and remote memory recall
por: Kim, Il Hwan, et al.
Publicado: (2014) -
Neural stem cell transplantation at critical period improves learning and memory through restoring synaptic impairment in Alzheimer's disease mouse model
por: Kim, J A, et al.
Publicado: (2015) -
Infantile Myelofibrosis and Myeloproliferation with CDC42
Dysfunction
por: Verboon, Jeffrey M., et al.
Publicado: (2020) -
Neuregulin-1 attenuates cognitive function impairments in a transgenic mouse model of Alzheimer's disease
por: Ryu, J, et al.
Publicado: (2016) -
Analysis of Motor Function in the Tg4-42 Mouse Model of Alzheimer’s Disease
por: Wagner, Jannek M., et al.
Publicado: (2019)